RASHA BOTROS: Open Payments
NPI 1598351835 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,289 in 96 payments from 18 companies in 2025. Trend: 2023 $1,001 · 2024 $1,645 · 2025 $2,289
Food & beverage: $2,271Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $452 |
| Insmed, Inc. | 11 | $239 |
| Regeneron Healthcare Solutions, Inc. | 9 | $229 |
| JAZZ PHARMACEUTICALS INC. | 9 | $217 |
| AstraZeneca Pharmaceuticals LP | 6 | $191 |
| Viatris Specialty LLC | 8 | $189 |
| GENZYME CORPORATION | 7 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $138 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| HARMONY BIOSCIENCES LLC | 2 | $79 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Arikayce, XYWAV, YUPELRI, AIRSUPRA, GLASSIA, NUCALA.
Industry payments across FL — which companies pay providers there.
